Forbion announces first close of its new BioEconomy Fund I: backing biotech-enabled companies aiming to impact the future of our planet
20 juin 2024 01h25 HE
|
Forbion
Forbion announces the first close of its latest fund, Forbion BioEconomy Fund I (“Forbion BioEconomy"), at €75 million.
Longeveron Raises $4.4 Million in Gross Proceeds from Warrant Exercise Transaction
18 juin 2024 16h48 HE
|
Longeveron
Longeveron raises $4.4 Million in gross proceeds from warrant exercise transaction to fund development of its cellular therapy Lomecel-B
Evergold Closes $1,072,000 Private Placement to Support Follow-up Drilling at Emerging DEM1 Gold-Silver++ Discovery, BC
12 juin 2024 07h00 HE
|
Evergold Corp.
Evergold Closes $1,072,000 Private Placement to Support Follow-up Drilling at Emerging DEM1 Gold-Silver++ Discovery, BC
Tevogen Bio Enters Into Agreement for Up to $50 Million in Financing to Advance R&D and Clinical Development Efforts
11 juin 2024 15h30 HE
|
Tevogen Bio Inc
Agreement for Up to $50 Million in Financing. Includes $36 million line of credit and potential $14 million private placement.
Alaska Energy Metals Announces Financing and Planned Corporate Changes
07 juin 2024 14h39 HE
|
Alaska Energy Metals Corporation
Not for Distribution to United States Newswire Services or for dissemination in the United States Highlights: Alaska Energy Metals plans to raise $3 million to drill the highly prospective Canwell...
Gorilla Announces $12 Million Registered Direct Offering
07 juin 2024 08h00 HE
|
Gorilla Technology Group Inc.
LONDON, June 07, 2024 (GLOBE NEWSWIRE) -- Gorilla Technology Group Inc. (“Gorilla” or the “Company”) (NASDAQ: GRRR), a global solution provider in Security Intelligence, Network Intelligence,...
ITM Raises €188m to Enhance Radiopharmaceutical Pipeline and to Strengthen Leading Position in Medical Radioisotope Manufacturing
06 juin 2024 05h00 HE
|
ITM Isotope Technologies Munich SE
Proceeds to support development of ITM’s targeted radiopharmaceutical pipeline and preparations for potential market launch of phase III lead candidate, ITM-11, as it nears clinical read-out Funds...
BioSig Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
30 mai 2024 16h05 HE
|
BioSig Technologies, Inc.
Westport, CT, May 30, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company committed to delivering unprecedented accuracy and...
Celcuity Announces Pricing of Underwritten Common Stock Offering
30 mai 2024 07h36 HE
|
Celcuity Inc.
MINNEAPOLIS, May 30, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the...
Genelux Corporation Announces Proposed Public Offering of Common Stock and Warrants
23 mai 2024 16h01 HE
|
Genelux Corporation
Genelux Corporation Announces Proposed Public Offering of Common Stock and Warrants